Tranexamic acid
Tranexamic Acid is a prescription injectable medication used to help control excessive bleeding by preventing the breakdown of blood clots. It is administered intravenously as a 100 mg/mL solution in single-use vials. This generic drug is manufactured by Heritage Pharmaceuticals and Methapharm. This information was generated using AI and is provided for informational and research purposes only.
Find Related Datasets
Search by Tags
Click any tag below to search for similar datasets
Complete Metadata
| @type | dcat:Dataset |
|---|---|
| accessLevel | public |
| accrualPeriodicity | R/P1Y |
| bureauCode |
[
"009:10"
]
|
| contactPoint |
{
"fn": "Division of Drug Information",
"@type": "vcard:Contact",
"hasEmail": "mailto:druginfo@fda.hhs.gov"
}
|
| description | Tranexamic Acid is a prescription injectable medication used to help control excessive bleeding by preventing the breakdown of blood clots. It is administered intravenously as a 100 mg/mL solution in single-use vials. This generic drug is manufactured by Heritage Pharmaceuticals and Methapharm. This information was generated using AI and is provided for informational and research purposes only. |
| distribution |
[
{
"@type": "dcat:Distribution",
"title": "Tranexamic acid",
"mediaType": "text/html",
"description": "
Access the FDA dataset for Tranexamic acid — ANDA 202093 submitted by Mylan Institutional LLC
",
"downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202093"
}
]
|
| identifier | ANDA202093 |
| issued | 2016-09-16 |
| keyword |
[
"drug",
"drug-information",
"drug-manufacturers",
"drug-safety",
"prescription-drugs"
]
|
| landingPage | https://www.fda.gov/drugs |
| license | https://open.fda.gov/license |
| modified | 2025-03-17 |
| programCode |
[
"009:002"
]
|
| publisher |
{
"name": "U.S. Food and Drug Administration",
"@type": "org:Organization"
}
|
| theme |
[
"FDA"
]
|
| title | Tranexamic acid |
